GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
S

SK Biopharmaceuticals Co 326030.KS · KRW

Health Care · KRX · 🇰🇷 South Korea

Compare

86,700

-2.36%

Close of 9 Nov 2026, in KRW

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Latest on SK Biopharmaceuticals Co

Our reporting

Next results

5 Nov 2026

Due on 5 Nov 2026. Analysts expect earnings of 763.93 a share on revenue of ₩251.35bn.

Past results

Reported against what analysts expected

5 Aug 20267 May 20266 Feb 20265 Nov 20255 Aug 20255 Feb 2025
Earnings per share581.551311.791694.99947.00420.002427.63
Forecast563.67481.02434.02342.46390.33236.84
Revenue₩247.37bn₩227.90bn₩194.40bn₩191.73bn₩176.28bn₩163.02bn
Forecast₩242.74bn₩214.47bn₩193.81bn₩202.52bn₩183.92bn₩158.00bn

Key events

  1. 2 Jul 2020Listed

Sources and methodology

Data on this tab
Our reporting and our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.